Therapeutic Efficacy of Novel Antimicrobial Peptide AA139-Nanomedicines in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats

Antimicrobial peptides (AMPs) have seen limited clinical use as antimicrobial agents, largely due to issues relating to toxicity, short biological half-life, and lack of efficacy against Gram-negative bacteria. However, the development of novel AMP-nanomedicines, i.e., AMPs entrapped in nanoparticle...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: van der Weide, Hessel, Cossío, Unai, Gracia, Raquel, te Welscher, Yvonne M., ten Kate, Marian T., van der Meijden, Aart, Marradi, Marco, Ritsema, Jeffrey A. S., Vermeulen-de Jongh, Denise M. C., Storm, Gert, Goessens, Wil H. F., Loinaz, Iraida, van Nostrum, Cornelus F., Llop, Jordi, Hays, John P., Bakker-Woudenberg, Irma A. J. M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2020
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449162/
https://ncbi.nlm.nih.gov/pubmed/32540976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00517-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars